9013

Pharmaceutical manufacturers Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., both subsidiaries of Johnson & Johnson, agreed to pay more than 24 million to settle multistate litigation alleging they promoted the epilepsy drug Topamax for uses not approved by the Food and Drug Administration. This was part of a larger 81 million civil and criminal settlement involving the federal government; ###-ortho-mcneil-pharmaceutical-llc